Nadège Pelletier
Hoofd Techniek/Wetenschap/O&O bij BARINTHUS BIOTHERAPEUTICS PLC
Vermogen: - $ op 30-04-2024
Actieve functies van Nadège Pelletier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 01-02-2023 | - |
Loopbaan van Nadège Pelletier
Eerdere bekende functies van Nadège Pelletier
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Opleiding van Nadège Pelletier
| Université Claude Bernard Lyon 1 | Doctorate Degree |
| École Normale Supérieure de Lyon | Graduate Degree |
Statistieken
Internationaal
| Frankrijk | 3 |
| Verenigd Koninkrijk | 2 |
| Verenigde Staten | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Beurs
- Insiders
- Nadège Pelletier
- Ervaring